Curate Biosciences - Transformative Cell Processing for Next-Generation Therapies
At Curate Biosciences we see a future where patients, clinicians, innovators, and payors routinely embrace cell and gene therapies against intractable disease.
To help make this future a reality, we focus on advancing our platform technology, Deterministic Cell Separation™, to deliver greater quantities of the highest quality cellular starting materials, faster and less costly, to the innovators, developers, and clinicians pushing the boundaries of the possible.
The Curate® Cell Processing System gently isolates leukocytes using Deterministic Cell Separation™ (DCS), an advanced, highspeed microfluidic technology that gently separates cells based on size. Optimized for processing apheresis and cell culture samples, the Curate obtains uniquely larger quantities of healthier leukocytes compared to other separation technologies.